laboratory crp of amer hldgs
Transactions by LABORATORY CRP OF AMER HLDGS (LH) in the last 6 months
Laboratory Corp. of America Holdings (NYSE:LH) entered into a definitive merger agreement to acquire LipoScience, Inc. (NasdaqGM:LPDX) from Armistice Capital LLC, Camden Partners Holdings, LLC, Cannell Capital LLC, Deerfield Capital, L.P., Deerfield Management Company, L.P., Pappas Ventures, Western Technology Investment, Three Arch Capital, TAC Associates, Sightline Healthcare and others for $83.8 million in cash on September 24, 2014. Laboratory Corp. will pay $5.25 ...
Camden Partners Holdings, LLC
Cannell Capital LLC
Deerfield Capital, L.P.
Deerfield Management Company, L.P.
INVESCO Private Capital
Oakwood Medical Investors
SightLine Healthcare Opportunity Fund, LLC
Three Arch Partners
Western Technology Investment
Seventh Sense Biosystems, Inc. announced that it will receive $16,467,084 in funding on July 28, 2014. The company will issue common shares, convertible debt and an option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. As of August 8, 2014, the company has received $10,467,084 in its first tranche close from eight investors.
Laboratory Corp. of America Holdings
Siemens Financial Services, Inc.
|Bio-Reference Laboratories Inc||$29.56 USD||+0.24|
|Genomic Health Inc||$34.84 USD||-0.04|
|Myriad Genetics Inc||$38.00 USD||+0.18|
|QIAGEN NV||€18.36 EUR||-0.211|
|Quest Diagnostics Inc||$63.68 USD||-0.06|
|View Industry Companies|